Lung cancer patients' CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

Minu K. Srivastava, Jacobus J. Bosch, James A. Thompson, Bruce R. Ksander, Martin Edelman, Suzanne Ostrand-Rosenberg

Research output: Contribution to journal › Article › peer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'Lung cancer patients' CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology